Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Nakaya

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|September 25, 2008
Sleep duration and the risk of breast cancer: the Ohsaki Cohort StudyM Kakizaki, S Kuriyama, T Sone, et al.
British Journal of Cancer|June 11, 2008
Sleep duration and the risk of prostate cancer: the Ohsaki Cohort StudyM Kakizaki, K Inoue, S Kuriyama, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 31, 2001
Changes in serotonin dynamics in the gastrointestinal tract of colon-26 tumour-bearing mice: effects of cisplatin treatmentY Nitta, M Nishibori, H Iwagaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
Histamine is a potent inducer of IL-18 and IFN-gamma in human peripheral blood mononuclear cellsH Kohka, M Nishibori, H Iwagaki, et al.
British Journal of Cancer|July 5, 2006
Personality traits and cancer survival: a Danish cohort studyN Nakaya, P E Hansen, I R Schapiro, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 24, 2005
Alcohol consumption and the risk of cancer in Japanese men: the Miyagi cohort studyN Nakaya, Y Tsubono, S Kuriyama, et al.
Arzneimittel-Forschung|April 1, 1986
Pharmacological profiles of 2-carboxyphenyl-1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate and 2-[(2-carboxyphenoxy)-carbonyl]phenyl-1-(4-chlorobenzoyl)-5-meth oxy-2- methylindole-3-acetate, new antiinflammatory agentsI Tanaka, H Yoshizumi, Y Tanaka, et al.
Atherosclerosis|August 1, 1988
Dose-dependent hypolipidemic effect of an inhibitor of HMG-CoA reductase, pravastatin (CS-514), in hypercholesterolemic subjects. A double blind testY Saito, Y Goto, N Nakaya, et al.
The American Journal of Cardiology|July 13, 1995
Clinical efficacy of fluvastatin for hyperlipidemia in Japanese patientsT Teramoto, Y Goto, K Kurokawa, et al.
International Psychogeriatrics|September 15, 2006
Validity and utility of the Japanese version of the WHO-Five Well-Being Index in the context of detecting suicidal ideation in elderly community residentsS Awata, P Bech, Y Koizumi, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|September 25, 2008
Sleep duration and the risk of breast cancer: the Ohsaki Cohort StudyM Kakizaki, S Kuriyama, T Sone, et al.
British Journal of Cancer|June 11, 2008
Sleep duration and the risk of prostate cancer: the Ohsaki Cohort StudyM Kakizaki, K Inoue, S Kuriyama, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 31, 2001
Changes in serotonin dynamics in the gastrointestinal tract of colon-26 tumour-bearing mice: effects of cisplatin treatmentY Nitta, M Nishibori, H Iwagaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
Histamine is a potent inducer of IL-18 and IFN-gamma in human peripheral blood mononuclear cellsH Kohka, M Nishibori, H Iwagaki, et al.
British Journal of Cancer|July 5, 2006
Personality traits and cancer survival: a Danish cohort studyN Nakaya, P E Hansen, I R Schapiro, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 24, 2005
Alcohol consumption and the risk of cancer in Japanese men: the Miyagi cohort studyN Nakaya, Y Tsubono, S Kuriyama, et al.
Arzneimittel-Forschung|April 1, 1986
Pharmacological profiles of 2-carboxyphenyl-1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate and 2-[(2-carboxyphenoxy)-carbonyl]phenyl-1-(4-chlorobenzoyl)-5-meth oxy-2- methylindole-3-acetate, new antiinflammatory agentsI Tanaka, H Yoshizumi, Y Tanaka, et al.
Atherosclerosis|August 1, 1988
Dose-dependent hypolipidemic effect of an inhibitor of HMG-CoA reductase, pravastatin (CS-514), in hypercholesterolemic subjects. A double blind testY Saito, Y Goto, N Nakaya, et al.
The American Journal of Cardiology|July 13, 1995
Clinical efficacy of fluvastatin for hyperlipidemia in Japanese patientsT Teramoto, Y Goto, K Kurokawa, et al.
International Psychogeriatrics|September 15, 2006
Validity and utility of the Japanese version of the WHO-Five Well-Being Index in the context of detecting suicidal ideation in elderly community residentsS Awata, P Bech, Y Koizumi, et al.
Pageof 7